In-vitro diagnostics refer to the analysis of blood, bodily fluid, or tissue samples taken from the human body. IVDs are useful for the detection of illnesses and other medical conditions, as well as the treatment, cure, and prevention of certain diseases. Additionally, in vitro diagnostics can be used in precision medicine to pinpoint specific treatments or therapies that may be effective for certain patients.

The surging trends of an aging global population, the prevalence of chronic diseases, and the rise in outbreaks of infectious diseases have helped to expand the growth of the in vitro diagnostics (IVD) industry in the past several years. The demand for personalization and ease of use in IVD products for consumers and the influence of information technology have helped to cultivate more innovation in the industry.

As the chronic disease burden grows worldwide, there is an increasing awareness that care needs to shift. Where diagnosis and monitoring were once focused solely on the hospital setting, it has become evident that this model is too expensive and inconvenient to patients to be useful and sustainable on a global scale. 

This webinar touches on the driving need for greater distribution of accessible tests; how guidelines proposed by globally recognized authorities such as the World Health Organization (WHO) inform diagnostic selection; and take a close look a the material properties of POC IVDs such as lateral flow test strips, Lab-on-chip (LOC), and micro paper-based analytic devices (μPADs).